Renate
Muller-Runkel,
Scatter to the
PhD
#{149} Urmi
Dose from Uninvolved
Thermoluminescent dosimeters (TLDs) were used to measure scatter radiation to the uninvolved breast in 30 patients who received tangential breast or chest-wall radiation with a technique in which the deep edges of the tangential fields were aligned. In most patients, measurements were made during the 1st week of radiation therapy, after port radiographs were obtained to ensure proper field position and accurate alignment of the posterior tangential field edges. Phantom measurements were made simultaneously with TLD measurements to systematically assess the scatter dose as a function of the wedging, number of fields, type of accelerator, beam energy, and bolus used in each treatment. For most patients, the scatter dose to the contralateral breast at a point on the skin 5 cm outside the edge of the medial beam was 8%-13% of the prescribed dose. However, higher doses (up to 36% of the therapeutic dose) were recorded in some patients. Index
terms:
00.33 gy,
Breast
#{149} Breast
cations, effects,
ogy,
00.47
#{149} Phantoms
compli-
#{149} Radiations,
injuri-
of therapeutic
#{149} Radiations,
00.33,
radiolo-
procedures,
complications
neoplastic,
metastases,
therapeutic
#{149}
00.47
ous
neoplasms,
neoplasms,
Interventional
00.129
injurious
00.47
radiol-
effects,
#{149} Radiations,
measure-
ment
Radiology
P. Kalokhe,
1990;
175:873-876
MD
Tangential Breast’
Breast
carcinogenesis is of particular concern in patients breast carcinoma who undergo
ADIATION
with
mastectomy
tion
varies
with
treatment
and
therapy
scopic
conservation surgery followed by radiation therapy. Many radiologists believe that carcinogenesis from exposure to low doses of radiation is minima! (four secondary breast cancers per 1,000 patients who undergo radiation therapy of the breast [1-4]), and latent periods of 10 or more years were reported (1). However, experience has been relatively limited, and few quantitative reports are available (5-7); these involve a vanety of treatment techniques. This study was undertaken to obtam measurements of scatter doses in patients who underwent radiation therapy for carcinoma of the breast. We attempted to identify subgroups of patients in whom scatter radiation to the uninvolved breast might be high and to explore ways to minimize such an unwanted dose. The scatter dose to the contralater-
a! breast
Irradiation
tech-
nique. It has been shown (6,7) that the dose to the medial pant of the contralateral breast can be reduced considerably when the deep edges of the tangential fields are aligned. We conducted measurements with thermoluminescent dosimeters (TLDs) in 30 patients who received tangential breast or chest-wall irmadiation with this technique on either an M-6700 accelerator (Mevatron; Siemens Medical Systems, Iselin, NJ) or a Cl-i800 accelerator (Clinac; Vanian, Palo Alto, Calif).
Among patients 1
From
the
Oncology
Hospital and Aye, Hammond, 1, 1989; vision
Health IN
revision
RSNA,
Centers, 46320.
requested
received
19. Address
Center,
February
reprint 1990
requests
Saint
5454 Received
disease.
treated only,
praclaviculam additional
with with
January
Hohman December 23,
to R.M.R.
1990; February
re-
in this
radiation cGy was
therapy. delivered
fractions with tangential by a boost dose of 1,400 tions, energy, Nine
delivered to the
study,
conservation
with tumor
of 30 patients
A target in 23
ports, followed cGy in seven frac-
electrons bed. had
21
surgery
and two mammary
were
unusually 18-MV
The
treated
either an accelerator. large photons
irradiation
duction breast the The
required field
with
breasts on the
Siddon of this
immadia6-MV
M-6700 acceleraSome patients were treated Cl-1800, in
used (Fig
technique
by
su-
an with
lung
which a metal bolus was appropriate dose buildup described achievement
cGy
Table 1 for the papatients were
excessive
patients
photons from tom or a Cl-1800
of 5,040
tangential fields with a matching
to avoid
tion. Most
madia-
or micro-
dose
opposing treated
field, internal
electrons
with
recurrent
A target
with 14 were
to achieve 1). we
et al (8). technique
used
was
A major is the
me-
of exposure of the contralateral to scatter radiation by alignment
deep edges supraclaviculam
optimize phalic
of the
the M-6700 jaws defined 1800,
accelerator, the the half-field;
a half-field
For
most
were
block
patients,
diogmaphs em field
of the
were position
alignment tangential
lead
wire
posing
1st week
approved
tangential
field
on
ma-
edges.
was visualized port radiograph the
medial
of
port
obtained to ensure propand accurate alignment
posterior
Such emal
On
used.
the
after
to ce-
measurements
during
therapy,
aligned ports. independent on the Cl-
was TLD
performed
radiation
of
tangential beams. field is a half-field
matching with the borders of the tangential
entry
border
tangential
on by
the latplacing
of the
op-
port.
For each dose measurement, three TLD chips (LiF, 3.0 X 3.0 X 0.9 mm) were wrapped in thin plastic foil and placed on the
patient’s
skin
tangential left
in
the
field.
The
during
For
internal
the
the
(measured the edge
TLD the
treatment
lam field.
contralatemal
in
lateral from
place
including an
on
approximately
plane, 5 cm skin surface)
METHODS
30 patients
underwent
followed by dose of 4,600
Margaret
12; accepted
the
AND
treated
was delivered in 28 fractions. shows the course of treatment tients in our study. Sixteen
breast,
PATIENTS
were
for either
mammary
along the the medial
of
probes
entire
of the two
central
supraclavicu-
patients field,
were treatment,
treated
with
measure-
of suitable
Abbreviations: undergone
TLD
=
SSD
thermoluminescent
source-to-skin
distance,
dosimeter.
873
S DO I00
18 MV
.,
UYERS
WLDP#{128}SH
20
50 40 30 10
18 MV
20
0-1800
6 MV
a
MV
M-6700
4
cm
1.
2.
Figures
skin
1, 2. distance
ments lateral border.
were from
(1) Percentage depth dose (DD) for 18-MV photons with various layers [SSD]). (2) Surface dose for 15 X 15-cm field at an SSD of 100 cm. dmax
made at 5-cm distance the internal mammary
A distance this
contrafield
of 5 cm was chosen
point
usually
falls
because
halfway
between
the patient’s midline and the apex of the contralatemal breast. It is well outside the beam penumbra, and a significant amount of contralatemal breast tissue is present at this distance. The TLD measurements were repeated during the 3rd week of treatment. At this time, an additional TLD was placed in the opposing midaxilla in some patients. The intent was to assess a lower limit of the scatter dose to the opposite breast.
For each measurement, selected with a relative tion
of less
reference equivalent
than
± 2%.
TLD chips were sensitivity variaOn
the
same
day,
TLDs were exposed in a waterplastic phantom to a known
scatter doses at 5 cm contralateral from the medial port were 19.6%, 27.5%, and 36.3%, respectively, of the therapeutic dose to the treated breast. For a tumor dose of 4,600 cGy, 25% amounts to 1,150 cGy to the uninvolved breast. These patients were treated with 18-MV photons; one or more layers of metal bolus were used. As will be shown below, the higher
energy degree
and bolus responsible
scatter dose. protruding
the medial tangential al (6) showed that
creases
read
lam distance
Made
during
Table 2 summarizes the results of our TLD measurements. For most patients the scatter dose to the medial aspect of the contralatenal breast was 8%-13%
of the
therapeutic
dose
de-
livened. The medial gantry angle seems to have had little influence. There was a slight dependence on the size of wedge that was used. Patients treated with 18-MV photons and a metal bolus seemed to receive higher scatter doses than those who were treated with the lower energy and no bolus. Three patients stand out: Their 874
Radiology
#{149}
significant and large
are
the
with
edge. and
field. scatter
increasing from
For a large, shallow
Fraass dose de-
et
perpendicu-
the
geometric
field
protruding
medial
gantry
this distance is shorter shallow, small breast
breast angle,
than for and steep
a medi-
a! gantry angle. The dose to the opposing midaxilla ranged, for all patients, between 1% and 3% of the therapeutic dose. Port
RESULTS Measurements Treatment
More shape
are only to some for such a high
volume of these patients’ breasts, which placed the surface of the contralateral breast relatively close to the edge of
dose.
Reference and patient TLDs were 1 day after exposure on a 4000 TLD system (Harshaw/Filtrol Partnership, Cleveland). The readings from the three chips were averaged.
of metal bolus (10 X 10-cm2 field at 100 cm source-todepth of maximum dose buildup.
nadiographs with a field en for the second exposure the dose to the contralateral
about
3 cGy
Phantom
pen radiograph.
how
the
in a systematic scatter
dose
man-
is influ-
enced by the kinds of accelerator, wedge, beam energy, and bolus that are used, we performed the following
in-phantom
Scatter dose field.-Surface tances
from
measurements: outside open and wedged doses at various disthe geometric field edge
field
were measured parallel-plate
chamber (Markus; PhysikalischTechnische Werkstaetten, Freihurg, Federal Republic of Germany) in a solid ation Wis).
water phantom Measurements, For this purpose,
(RMI 457; RadiMiddleton, the surface of
the chamber was placed at the appropniate distance from the source (SSD), and all readings were normalized to a reading obtained with the chamber at the
Measurements
To investigate ner
opened widincreased breast by
of a i5 X 15-cm with a thin-window
center
the
depth
(1.5
cm
of the
respective
of maximum for
6-MV
x rays
field
dose
buildup
and
3 cm
at for
18-MV x rays). Measurements of the surface doses are shown in Figure 2. The observed difference between machines in doses outside the treated area was due mainly to difference in design: the lower collimators on the M-6700 isocentnic
are
10 cm farther from plane than those on
the the
June
Cl-
1990
Table 2 Measured
Surface
to Contralateral
Dose
at 5 cm Outside
Breast
Field
Wedge
Angle
Dose to Contralateral Breast
(degrees)
(degrees)
at 5 cm*
Medial Field Patient No.
Accel-
Energy
emator
(MV)
T T
M-6700
6 6
30 30 30
60 39 53
8.3 6.8 10.9
6
30
56
13.4
6 6
45
52
8.7
6 18
45 30 15
57 46 56
9.8 8.3 19.6
M-6700
6
30
M-6700 M-6700 M-6700
6 6 6
30 Large 30 30
56 52
10.1 14.1
60 49
10.6 6.5
6
15
59
12.4
30
56
27.5
15 15
50 50
8.3 11.8
45 45
53 58
12.5 36.3
45 Large 60 Large 45 Large 30
55 59 56 58
10.0 12.3 11.6 10.9
11 12
T + S/Cl T
M-6700 M-6700
6 6
14
T
M-6700
6
15
T
M-6700
16
T
M-6700
17 18 20
T T T
M-6700 M-6700 Cl-1800
21
T
22 25
T + S/Cl T + S/Cl T
26
T
M-6700
27
T + S/Cl
Cl-1800
28 29
T T
1 5
30 45
6 45 Large 6 30 18 + 6 + 16 30
18 + 6
6 6
M-6700 M-6700
T + S/Cl T + S/Cl T + S/Cl T + S/Cl
18 + 6 18 + 6
Cl-1800
10
T + S/Cl
13
T+S/Cl+IM
Cl-1800 M-6700 M-6700 M-6700 Cl-1800
19
T+S/Cl
M-6700
6
30
53
12.2
24
T + S/Cl
M-6700
6
45
Cl-1800
6
45
52 67
12.1 7.5
6 7
30
Table
12.9 10.6 13.3
T 1 + S/Cl + IM
patients
=
49 57 45
T + S/Cl
8 9
Mastectomy
Percentage
10.0 10.0
M-6700 M-6700 M-6700 Cl-1800
23
*
48 52
2 3 4
Lumpectomy patients
Note.-T
Gantry
Arrangement
tangential, of dose
T S/Cl
supraclavicular,
prescribed
6 6 6 6+6+12
IM
for treated
internal
breast.
mammary.
wedge
material.
Dose
at 5 cm Outside
Field
for Open
and Wedged
15
Field
X 15-cm
at 100
cm SSD 300
Accelerator (Energy) M-6700
(6 MV) Cl-1800
(6 MV) Cl-1800
(18MV) Note-Values
Open
Small
Open Field
300 Small
with
with
Depth
Large
Small
Large
Tray
Tray
SurfaceI cm Surface1 cm Surface1cm
5.1 2.8 8.8 5.5 11.6 11.0
5.3 3.4 9.4
6.5 6.8 10.0
6.6 5.6 11.0
9.1 11.9 11.8
7.4 3.3 10.7
7.4 3.6 12.8
7.7
8.9
10.8
11.6
5.8
8.2
11.9 11.8
12.0 12.0
15.5 16.6
16.0 16.3
12.8 11.2
13.0 12.3
are
percentages
of dose
30#{176}
60#{176}
60#{176}
at dmax.
slope
were
obtained
has “small-field” up to 20 cm wide Volume
175
(9).
Number
#{149}
The
M-6700
wedges for fields and “lange-field” 3
wedges for fields the wedge slope. tients, the small
whenever As can scatter
gle and
up to 30 cm across For treatment of pawedges are used
possible.
be seen from Table 3, the dose increases with wedge an-
is higher
for the M-6700 ence between
for the accelerator. smalland
Cl-1800
than
The differlarge-field
wedges is less pronounced at the sunface than at a depth of 1 cm, indicating that the scatter component from large-field wedges is more energetic than that from small-field wedges. A block tray increases the scatter dose at the patient’s skin but has little effect on the scatter dose at depth.
of 1 cm,
a
will
receive
a considerably
higher dose to the contralateral breast than a patient treated with a steep medial gantry angle and no wedge. This effect is enhanced for a large, protruding breast. Influence offield separation.-The medial gantry angle is influenced to some extent by the separation be-
tween points fields. only angle,
the
medial
and
lateral
entry
of the opposing tangential A large sepanation may not imply a shallow medial gantry it also means a reduced dis-
tance
1800. For the same energy, scatter doses outside the treated area were generally twice as high on the Cli800 as on the M-6700, and even higher when 18-MV photons were used. Table 3 lists scatter doses at 5 cm outside the geometric field edge for open and wedged fields with and without a block tray. The standard wedges on the Cl1800 are designed for fields up to 15 cm wide; custom-made wedges for fields up to 30 cm across the wedge
At a depth
dependence on gantry angle and wedges was seen. In addition, the effect of beam hardening in the large-field wedges could be observed. These measurements demonstrate that a patient treated with a shallow medial gantry angle and a thick similar
wedge
3
Scatter
No significant increase (